Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TERN-701
i
Other names:
TERN-701, TRN-000632, HS-10382
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Jiangsu Hansoh Pharma, Terns Pharma
Drug class:
Bcr-abl tyrosine kinase inhibitor
Related drugs:
‹
dasatinib (215)
imatinib (166)
nilotinib (66)
bosutinib (46)
asciminib (14)
olverembatinib (12)
flumatinib (5)
INNO-406 (3)
TGRX-678 (2)
KF-1601 (1)
PF-114 (1)
SCO - 088 (1)
AZD 0424 (0)
dasatinib amorphous (0)
ELVN-001 (0)
KW-2449 (0)
radotinib (0)
XL228 (0)
PHA-739358 (0)
AER-901 (0)
SKLB-1028 (0)
dasatinib (215)
imatinib (166)
nilotinib (66)
bosutinib (46)
asciminib (14)
olverembatinib (12)
flumatinib (5)
INNO-406 (3)
TGRX-678 (2)
KF-1601 (1)
PF-114 (1)
SCO - 088 (1)
AZD 0424 (0)
dasatinib amorphous (0)
ELVN-001 (0)
KW-2449 (0)
radotinib (0)
XL228 (0)
PHA-739358 (0)
AER-901 (0)
SKLB-1028 (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
CARDINAL- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (NCT06163430)
Phase 1
Terns, Inc.
Terns, Inc.
Not yet recruiting
Phase 1
Terns, Inc.
Not yet recruiting
Last update posted :
12/08/2023
Initiation :
12/13/2023
Primary completion :
11/30/2025
Completion :
05/31/2026
ABL1 • BCR
|
TERN-701
A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. (NCT05367700)
Phase 1
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Recruiting
Phase 1
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Recruiting
Last update posted :
01/13/2023
Initiation :
04/28/2022
Primary completion :
12/30/2024
Completion :
09/30/2026
ABL1 • BCR
|
BCR-ABL1 fusion
|
TERN-701
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login